Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Multiple Sclerosis

  Free Subscription


Articles published in J Clin Invest

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    December 2023
  1. JOHANN L, Soldati S, Muller K, Lampe J, et al
    A20 regulates lymphocyte adhesion in murine neuroinflammation by restricting endothelial ICOSL expression in the CNS.
    J Clin Invest. 2023;133:e168314.
    PubMed     Abstract available


    September 2023
  2. CLARKSON BD, Grund EM, Standiford MM, Mirchia K, et al
    CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis.
    J Clin Invest. 2023 Sep 7:e162788. doi: 10.1172/JCI162788.
    PubMed     Abstract available


    August 2023
  3. OWENS GP, Fellin TJ, Matschulat A, Salas V, et al
    Pathogenic myelin specific antibodies in multiple sclerosis target conformational proteolipid protein 1 anchored membrane domains.
    J Clin Invest. 2023 Aug 10:e162731. doi: 10.1172/JCI162731.
    PubMed     Abstract available


    May 2023
  4. KERKERING J, Muinjonov B, Rosiewicz KS, Diecke S, et al
    iPSC-derived reactive astrocytes from patients with multiple-sclerosis protect cocultured neurons in inflammatory conditions.
    J Clin Invest. 2023 May 23:e164637. doi: 10.1172/JCI164637.
    PubMed     Abstract available


  5. REDER AT
    Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse models.
    J Clin Invest. 2023;133:e169643.
    PubMed     Abstract available


  6. MA Y, Sannino D, Linden JR, Haigh S, et al
    Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.
    J Clin Invest. 2023;133:e163239.
    PubMed     Abstract available


    April 2023
  7. ANTEL JP, Kennedy TE, Kuhlmann T
    Seeking neuroprotection in multiple sclerosis: an ongoing challenge.
    J Clin Invest. 2023;133:e168595.
    PubMed     Abstract available


  8. KAPELL H, Fazio L, Dyckow J, Schwarz S, et al
    Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.
    J Clin Invest. 2023;133:e164223.
    PubMed     Abstract available


    October 2022
  9. ASASHIMA H, Axisa PP, Pham THG, Longbrake EE, et al
    Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


    September 2022
  10. HORWITZ RI, Hayes-Conroy A, Singer BH, Cullen MR, et al
    Falling down the biological rabbit hole: Epstein-Barr virus, biography, and multiple sclerosis.
    J Clin Invest. 2022;132.
    PubMed    


    May 2022
  11. FUJIWARA M, Raheja R, Garo LP, Ajay AK, et al
    microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
    J Clin Invest. 2022;132.
    PubMed     Abstract available


  12. TYLER KL
    The enigmatic links between Epstein-Barr virus infection and multiple sclerosis.
    J Clin Invest. 2022;132.
    PubMed    


    July 2021
  13. GHEZZI L, Cantoni C, Pinget GV, Zhou Y, et al
    Targeting the gut to treat multiple sclerosis.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    June 2021
  14. SINGH AK, Netea MG, Bishai WR
    BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.
    J Clin Invest. 2021;131.
    PubMed     Abstract available


    November 2020
  15. POMPURA SL, Wagner A, Kitz A, Laperche J, et al
    Oleic acid restores suppressive defects in tissue-resident FOXP3 regulatory T cells from patients with multiple sclerosis.
    J Clin Invest. 2020 Nov 10. pii: 138519. doi: 10.1172/JCI138519.
    PubMed     Abstract available


    April 2020
  16. LI Z, Korhonen EA, Merlini A, Strauss J, et al
    Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    J Clin Invest. 2020;130:1977-1990.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.